Home › Funds › Kintegral Advisory, LLC › EW

Kintegral Advisory, LLC position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Kintegral Advisory, LLC reported holding 63,507 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q2 2026 13F filing — a position valued at US$5.7M, representing 0.47% of its reported portfolio and ranking #49 among its reported holdings. Kintegral Advisory, LLC first reported this position in Q2 2026.

Latest position (Q2 2026)63.51K sh
Reported value held$5.74M
Portfolio Weight0.47%
First reportedQ2 2026
Last changeNew

How Kintegral Advisory, LLC's EW position evolved

Kintegral Advisory, LLC first disclosed a stake in EW in Q2 2026 at 63,507 shares (US$5.7M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 63.51K $5.74M New

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 218 other funds we track also report a position in EW — the largest reported positions include Vanguard Group (US$5.97B), BlackRock Inc (US$5.32B), VANGUARD CAPITAL MANAGEMENT LLC (US$3.40B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →